Is Tilray a Buy?

Zhiyuan Sun, The Motley Fool
·4-min read
Is Tilray a Buy?

Tilray (NASDAQ: TLRY) is about to become the biggest cannabis company in the world in terms of revenue, thanks to a merger with Canadian pot producer Aphria (NASDAQ: APHA). The problem with Tilray's stock was overvaluation. During Q3 2021 (ended Feb. 28), Aphria grew its revenue by just 6.4% from the year-prior period to $153.6 million Canadian dollars.